Found 4883 articles for: "Ted Rosen/page/73/ht...<br><a class="
Successful Treatment of Dystrophic Epidermolysis Bullosa With the JAK1 Inhibitor Abrocitinib
April 2026 | Volume 25 | Issue 4 | Case Reports | 384 | Copyright © April 2026
Introduction: JAK inhibitors are increasingly being utilized for the treatment of diseases beyond their nonclassical indications, and thehighly selective JAK1 inhibi...
Read MoreFULL SUPPLEMENT: Real World Cases of a Novel Topical Tranexamic Acid Serum in Treatment of Hyperpigmentation
April 2026 | Volume 25 | Issue 4 | Department | 154700s3 | Copyright © April 2026
Hyperpigmentation and dyschromia are amongst the most common dermatologic concerns for patients seeking care.1 They can affect patients of all skin types and ages, and most commonly occurs ...
Read MoreINDIVIDUAL ARTICLE: Real World Use of Topical Tranexamic Acid Serum in Patients With Hyperpigmentation
April 2026 | Volume 25 | Issue 4 | Supplement Individual Articles | 154701s3 | Copyright © April 2026
Hyperpigmentation and pigmentary alterations are common dermatologic concerns that remain difficult to treat. The modernized topical tranexamic acid serum (TNXA-SHOT) is a novel, patent-pending s...
Read MoreRacial and Ethnic Representation in Clinical Trials of Janus Kinase Inhibitors for Dermatologic Conditions: A Systematic Review
April 2026 | Volume 25 | Issue 4 | Original Article | 316 | Copyright © April 2026
Background: Janus kinase (JAK) inhibitors represent promising therapies for dermatologic conditions, including psoriasis, hidradenitis suppurativa (HS), atopic dermatitis (AD), s...
Read MoreExosome-Based Therapies in Dermatology: A Scoping Review
April 2026 | Volume 25 | Issue 4 | Original Article | 368 | Copyright © April 2026
Background: In pre-clinical studies, exosomes activate dermal repair mechanisms, and they may show regenerative potential for skin rejuvenation, pigmentation, scarring, hair loss...
Read MoreAn Investigator-Developed Regimen for Treatment and Prevention of Post-Inflammatory Hyperpigmentation in Skin of Color
April 2026 | Volume 25 | Issue 4 | Original Article | 330 | Copyright © April 2026
Background: There is an unmet demand for a post-inflammatory hyperpigmentation (PIH) treatment and prevention that is not only effective and accessible, but also safe to use in d...
Read MoreHydroquinone and Emerging Depigmenting Agents: Clinical Guidelines, Regulatory History, and Global Safety Considerations
April 2026 | Volume 25 | Issue 4 | Original Article | 363 | Copyright © April 2026
Hydroquinone has long served as the gold standard for hyperpigmentation treatment, but safety concerns, regulatory changes, and growing interest in non-hydroquinone therapies have prompted reeval...
Read MoreEruptive Lentiginosis Within Resolved Psoriasis Plaques: A Case Report and Systematic Review of the Literature
April 2026 | Volume 25 | Issue 4 | Original Article | 324 | Copyright © April 2026
Background: Many patients with psoriasis suffer from post-inflammatory pigmentary alteration (PIPA), which remains an unmet treatment need. Eruptive lentiginosis (EL) is a rare f...
Read MorePatient Interest in Dermatologists in the United States: A 20-Year Google Trends and Workforce Analysis
April 2026 | Volume 25 | Issue 4 | Original Article | 357 | Copyright © April 2026
Background: Dermatologists remain unevenly distributed throughout the United States (US), leading to disparities in access to dermatologic care.Objective:Read MoreDiagnostic Accuracy and Pitfalls of Publicly Available Artificial Intelligence Models for Nail Disorders
April 2026 | Volume 25 | Issue 4 | Original Article | 349 | Copyright © April 2026
Background: Artificial intelligence is increasingly applied to dermatology, yet its reliability in clinically high-stakes subspecialty domains such as nail disease remains poorly...
Read MoreThe State of Primary Hyperhidrosis: Therapeutic Advancements and National Representation
April 2026 | Volume 25 | Issue 4 | Features | 397 | Copyright © April 2026
The Dermoepidermal Junction as the Initiation Point for Reversal of Dermatoporosis
April 2026 | Volume 25 | Issue 4 | Original Article | 377 | Copyright © April 2026
Background: Dermatoporosis (DP) or chronic cutaneous fragility syndrome has traditionally been linked to extracellular matrix (ECM) dehydration, reduced cellular turnover, epider...
Read MoreObjective Measures Needed: Dermatology Program Directors' Perspectives on the USMLE Step 1 Pass/Fail Transition
April 2026 | Volume 25 | Issue 4 | Original Article | 345 | Copyright © April 2026
Background: Since January 2022, the United States Medical Licensing Examination (USMLE) Step 1 discontinued reporting a 3-digit score. The objective of this study is to share sur...
Read MoreRemibrutinib: Insights Into Its Mechanism of Action and Use for Dermatologic Conditions
April 2026 | Volume 25 | Issue 4 | Original Article | 311 | Copyright © April 2026
Objective: Chronic spontaneous urticaria (CSU) is a chronic, debilitating condition characterized by recurrent wheals and/or angioedema. Several cytokines have been linked to CSU...
Read MoreBeyond Efficacy: 0.6% Selenium Disulfide Shampoo Matches 2% Ketoconazole for Seborrheic Dermatitis with Superior Cosmesis
April 2026 | Volume 25 | Issue 4 | Original Article | 338 | Copyright © April 2026
Background: Although most dandruff shampoos are effective, many leave hair dry and unmanageable, potentially impacting patient compliance and treatment outcomes.Obje...
Read MoreDelays in Medical Care Among Skin of Color Melanoma Patients: A Population-Based Study
April 2026 | Volume 25 | Issue 4 | Features | 391 | Copyright © April 2026
Association Between Topical Ruxolitinib Treatment and Psychiatric Outcomes in Adults With Vitiligo
April 2026 | Volume 25 | Issue 4 | Features | 388 | Copyright © April 2026
Rapid Clearance of Lichen Planus With Topical Tapinarof
April 2026 | Volume 25 | Issue 4 | Case Reports | 381 | Copyright © April 2026
Background: Lichen planus (LP) is an auto-inflammatory idiopathic condition affecting skin, mucous membranes, hair follicles, and nails that presents as pruritic, violaceous papu...
Read MoreTopical Vehicle Design: Educational Intervention Addresses Gap in Dermatology Resident Training
April 2026 | Volume 25 | Issue 4 | Editorials | e41 | Copyright © April 2026
The Safety of GLP1 Receptor Agonist Usage in Mohs Micrographic Surgery Patients
April 2026 | Volume 25 | Issue 4 | Editorials | 394 | Copyright © April 2026
Media and other results for: "Ted Rosen/page/73/ht...<br><a class="
No results found
© 2026 Journal of Drugs in Dermatology. All Rights Reserved. JDD, a peer-reviewed, MEDLINE®/PubMed® indexed journal, offers the dermatology community strong content of utmost quality and relevance on drugs, devices, and methods.
